329 related articles for article (PubMed ID: 23222893)
1. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.
Leventhal J; Abecassis M; Miller J; Gallon L; Tollerud D; Elliott MJ; Bozulic LD; Houston C; Sustento-Reodica N; Ildstad ST
Transplantation; 2013 Jan; 95(1):169-76. PubMed ID: 23222893
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
[TBL] [Abstract][Full Text] [Related]
3. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
Leventhal J; Abecassis M; Miller J; Gallon L; Ravindra K; Tollerud DJ; King B; Elliott MJ; Herzig G; Herzig R; Ildstad ST
Sci Transl Med; 2012 Mar; 4(124):124ra28. PubMed ID: 22399264
[TBL] [Abstract][Full Text] [Related]
4. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
Leventhal JR; Ildstad ST
Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
[TBL] [Abstract][Full Text] [Related]
5. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
6. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
[TBL] [Abstract][Full Text] [Related]
7. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance.
Leventhal JR; Mathew JM; Ildstad S; Salomon DR; Kurian SM; Suthanthiran M; Tambur A; Friedewald J; Gallon L; Charette J; Levitsky J; Kanwar Y; Abecassis M; Miller J
Clin Transpl; 2013; ():145-56. PubMed ID: 25095503
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants.
Leventhal JR; Elliott MJ; Yolcu ES; Bozulic LD; Tollerud DJ; Mathew JM; Konieczna I; Ison MG; Galvin J; Mehta J; Badder MD; Abecassis MM; Miller J; Gallon L; Ildstad ST
Transplantation; 2015 Feb; 99(2):288-98. PubMed ID: 25594553
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review.
Annamalai C; Kute V; Sheridan C; Halawa A
Transplant Rev (Orlando); 2023 Dec; 37(4):100792. PubMed ID: 37709652
[TBL] [Abstract][Full Text] [Related]
10. HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation.
Senev A; Tambur AR; Kosmoliaptsis V; Copley HC; García-Sánchez C; Usenko C; Ildstad ST; Leventhal JR
Front Immunol; 2024; 15():1377535. PubMed ID: 38601147
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
[TBL] [Abstract][Full Text] [Related]
13. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
Cosimi AB; Sachs DH; Sykes M; Kawai T
Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
[TBL] [Abstract][Full Text] [Related]
14. Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide.
Luznik L; Jalla S; Engstrom LW; Iannone R; Fuchs EJ
Blood; 2001 Dec; 98(12):3456-64. PubMed ID: 11719388
[TBL] [Abstract][Full Text] [Related]
15. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L
Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959
[TBL] [Abstract][Full Text] [Related]
16. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
Mackinnon S; Barnett L; Bourhis JH; Black P; Heller G; O'Reilly RJ
Blood; 1992 Dec; 80(12):3235-41. PubMed ID: 1467526
[TBL] [Abstract][Full Text] [Related]
17. Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.
Gallon L; Mathew JM; Bontha SV; Dumur CI; Dalal P; Nadimpalli L; Maluf DG; Shetty AA; Ildstad ST; Leventhal JR; Mas VR
J Am Soc Nephrol; 2018 Feb; 29(2):423-433. PubMed ID: 29191961
[TBL] [Abstract][Full Text] [Related]
18. Tolerance induction with donor hematopoietic stem cell infusion in kidney transplantation: a single-center experience in China with a 10-year follow-up.
Wang X; Yang C; Hu L; Wei Z; Tang Q; Chen B; Ji Y; Xu M; Zeng Z; Rong R; Zhu T
Ann Transl Med; 2020 Nov; 8(21):1378. PubMed ID: 33313123
[TBL] [Abstract][Full Text] [Related]
19. Facilitating cells as a venue to establish mixed chimerism and tolerance.
Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
[TBL] [Abstract][Full Text] [Related]
20. Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives.
Podestà MA; Sykes M
Front Immunol; 2021; 12():791725. PubMed ID: 35069574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]